MAR vs PFE: Which Is the Better Buy?
Side-by-side comparison of Marriott International, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Marriott International, Inc. · Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction
Grade C
VS
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
MAR has more upside to fair value
(+20.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MAR |
PFE |
| Current Price |
$334.97 |
$27.64 |
| Fair Value Estimate |
$403.81 |
$30.94 |
| Upside to Fair Value |
+20.6%
|
+12.0%
|
| Market Cap |
$87.3B |
$157.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
22.2x
|
17.4x
|
| Price / Sales |
3.2x
|
2.5x
|
| Price / FCF |
28.7x
|
14.3x
|
| Revenue Growth YoY |
+4.8%
|
+2.6%
|
| Gross Margin |
20.2%
|
71.3%
|
| Operating Margin |
15.8%
|
25.1%
|
| Return on Equity |
-66.7%
|
4.9%
|
| Dividend Yield |
0.84% |
6.22% |
| FCF Yield |
3.48%
|
6.97%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
| Metric |
MAR |
PFE |
| Zone Low |
$302.86 |
$23.21 |
| Zone High |
$343.24 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|